HEADER HYDROLASE 10-JAN-19 6QFH TITLE CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (N217D/I218Y/K224R) IN COMPLEX TITLE 2 WITH GSK144. COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALLIKREIN-6; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NEUROSIN,PROTEASE M,SP59,SERINE PROTEASE 18,SERINE PROTEASE COMPND 5 9,ZYME; COMPND 6 EC: 3.4.21.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KLK6, PRSS18, PRSS9; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS PROTEASE, INHIBITOR, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.H.THORPE REVDAT 4 16-OCT-24 6QFH 1 REMARK REVDAT 3 24-JAN-24 6QFH 1 REMARK REVDAT 2 15-MAY-19 6QFH 1 JRNL REVDAT 1 08-MAY-19 6QFH 0 JRNL AUTH J.H.THORPE,E.V.EDGAR,K.J.SMITH,X.Q.LEWELL,M.RELLA,G.V.WHITE, JRNL AUTH 2 O.POLYAKOVA,P.NASSAU,A.L.WALKER,D.S.HOLMES,A.C.PEARCE, JRNL AUTH 3 Y.WANG,J.LIDDLE,A.HOVNANIAN JRNL TITL EVALUATION OF A CRYSTALLOGRAPHIC SURROGATE FOR KALLIKREIN 5 JRNL TITL 2 IN THE DISCOVERY OF NOVEL INHIBITORS FOR NETHERTON SYNDROME. JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 75 385 2019 JRNL REFN ESSN 2053-230X JRNL PMID 31045568 JRNL DOI 10.1107/S2053230X19003169 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.1 REMARK 3 NUMBER OF REFLECTIONS : 44828 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2262 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 43.46 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1691 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2600 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1613 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.61 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 78 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3410 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 296 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.26240 REMARK 3 B22 (A**2) : 0.74340 REMARK 3 B33 (A**2) : -1.00580 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.30040 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.220 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.119 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.111 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.116 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.109 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3600 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4900 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1204 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 87 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 527 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3600 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 446 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4160 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.77 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.66 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QFH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1292100094. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.3.6 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44841 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 35.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.5 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.36700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1LO6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS-HCL PH 8.6, PEG 4000 18 REMARK 280 -28%, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 23.70000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 71 -53.37 -130.49 REMARK 500 GLN A 132 -70.51 -58.02 REMARK 500 THR A 133 116.16 -31.53 REMARK 500 SER A 195 132.44 -38.80 REMARK 500 SER B 214 -63.41 -123.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J08 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J08 B 303 DBREF 6QFH A 16 244 UNP Q92876 KLK6_HUMAN 22 243 DBREF 6QFH B 16 244 UNP Q92876 KLK6_HUMAN 22 243 SEQADV 6QFH GLY A 74 UNP Q92876 ARG 78 CONFLICT SEQADV 6QFH GLN A 76 UNP Q92876 ARG 80 CONFLICT SEQADV 6QFH GLN A 132 UNP Q92876 ASN 134 CONFLICT SEQADV 6QFH ASP A 217 UNP Q92876 ASN 215 ENGINEERED MUTATION SEQADV 6QFH TYR A 218 UNP Q92876 ILE 216 ENGINEERED MUTATION SEQADV 6QFH ARG A 224 UNP Q92876 LYS 223 ENGINEERED MUTATION SEQADV 6QFH GLY B 74 UNP Q92876 ARG 78 CONFLICT SEQADV 6QFH GLN B 76 UNP Q92876 ARG 80 CONFLICT SEQADV 6QFH GLN B 132 UNP Q92876 ASN 134 CONFLICT SEQADV 6QFH ASP B 217 UNP Q92876 ASN 215 ENGINEERED MUTATION SEQADV 6QFH TYR B 218 UNP Q92876 ILE 216 ENGINEERED MUTATION SEQADV 6QFH ARG B 224 UNP Q92876 LYS 223 ENGINEERED MUTATION SEQRES 1 A 222 LEU VAL HIS GLY GLY PRO CYS ASP LYS THR SER HIS PRO SEQRES 2 A 222 TYR GLN ALA ALA LEU TYR THR SER GLY HIS LEU LEU CYS SEQRES 3 A 222 GLY GLY VAL LEU ILE HIS PRO LEU TRP VAL LEU THR ALA SEQRES 4 A 222 ALA HIS CYS LYS LYS PRO ASN LEU GLN VAL PHE LEU GLY SEQRES 5 A 222 LYS HIS ASN LEU GLY GLN GLN GLU SER SER GLN GLU GLN SEQRES 6 A 222 SER SER VAL VAL ARG ALA VAL ILE HIS PRO ASP TYR ASP SEQRES 7 A 222 ALA ALA SER HIS ASP GLN ASP ILE MET LEU LEU ARG LEU SEQRES 8 A 222 ALA ARG PRO ALA LYS LEU SER GLU LEU ILE GLN PRO LEU SEQRES 9 A 222 PRO LEU GLU ARG ASP CYS SER ALA GLN THR THR SER CYS SEQRES 10 A 222 HIS ILE LEU GLY TRP GLY LYS THR ALA ASP GLY ASP PHE SEQRES 11 A 222 PRO ASP THR ILE GLN CYS ALA TYR ILE HIS LEU VAL SER SEQRES 12 A 222 ARG GLU GLU CYS GLU HIS ALA TYR PRO GLY GLN ILE THR SEQRES 13 A 222 GLN ASN MET LEU CYS ALA GLY ASP GLU LYS TYR GLY LYS SEQRES 14 A 222 ASP SER CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 A 222 GLY ASP HIS LEU ARG GLY LEU VAL SER TRP GLY ASP TYR SEQRES 16 A 222 PRO CYS GLY SER LYS GLU ARG PRO GLY VAL TYR THR ASN SEQRES 17 A 222 VAL CYS ARG TYR THR ASN TRP ILE GLN LYS THR ILE GLN SEQRES 18 A 222 ALA SEQRES 1 B 222 LEU VAL HIS GLY GLY PRO CYS ASP LYS THR SER HIS PRO SEQRES 2 B 222 TYR GLN ALA ALA LEU TYR THR SER GLY HIS LEU LEU CYS SEQRES 3 B 222 GLY GLY VAL LEU ILE HIS PRO LEU TRP VAL LEU THR ALA SEQRES 4 B 222 ALA HIS CYS LYS LYS PRO ASN LEU GLN VAL PHE LEU GLY SEQRES 5 B 222 LYS HIS ASN LEU GLY GLN GLN GLU SER SER GLN GLU GLN SEQRES 6 B 222 SER SER VAL VAL ARG ALA VAL ILE HIS PRO ASP TYR ASP SEQRES 7 B 222 ALA ALA SER HIS ASP GLN ASP ILE MET LEU LEU ARG LEU SEQRES 8 B 222 ALA ARG PRO ALA LYS LEU SER GLU LEU ILE GLN PRO LEU SEQRES 9 B 222 PRO LEU GLU ARG ASP CYS SER ALA GLN THR THR SER CYS SEQRES 10 B 222 HIS ILE LEU GLY TRP GLY LYS THR ALA ASP GLY ASP PHE SEQRES 11 B 222 PRO ASP THR ILE GLN CYS ALA TYR ILE HIS LEU VAL SER SEQRES 12 B 222 ARG GLU GLU CYS GLU HIS ALA TYR PRO GLY GLN ILE THR SEQRES 13 B 222 GLN ASN MET LEU CYS ALA GLY ASP GLU LYS TYR GLY LYS SEQRES 14 B 222 ASP SER CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 B 222 GLY ASP HIS LEU ARG GLY LEU VAL SER TRP GLY ASP TYR SEQRES 16 B 222 PRO CYS GLY SER LYS GLU ARG PRO GLY VAL TYR THR ASN SEQRES 17 B 222 VAL CYS ARG TYR THR ASN TRP ILE GLN LYS THR ILE GLN SEQRES 18 B 222 ALA HET J08 A 301 30 HET GOL B 301 6 HET GOL B 302 6 HET J08 B 303 30 HETNAM J08 4-[(5-PHENYL-1~{H}-IMIDAZOL-2-YL)METHYLAMINO]-2- HETNAM 2 J08 (PYRIDIN-3-YLMETHOXY)BENZENECARBOXIMIDAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 J08 2(C23 H22 N6 O) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 7 HOH *296(H2 O) HELIX 1 AA1 ALA A 55 LYS A 59 5 5 HELIX 2 AA2 SER A 164 TYR A 172 1 9 HELIX 3 AA3 TYR A 234 ALA A 244 1 11 HELIX 4 AA4 ALA B 55 LYS B 59 5 5 HELIX 5 AA5 SER B 164 TYR B 172 1 9 HELIX 6 AA6 TYR B 234 GLN B 243 1 10 SHEET 1 AA1 8 GLY A 20 PRO A 21 0 SHEET 2 AA1 8 GLN A 156 VAL A 163 -1 O CYS A 157 N GLY A 20 SHEET 3 AA1 8 MET A 180 GLY A 184 -1 O CYS A 182 N VAL A 163 SHEET 4 AA1 8 GLY A 226 ASN A 230 -1 O TYR A 228 N LEU A 181 SHEET 5 AA1 8 HIS A 208 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 CYS A 201 -1 N LEU A 199 O ARG A 210 SHEET 7 AA1 8 SER A 135 GLY A 140 -1 N HIS A 137 O VAL A 200 SHEET 8 AA1 8 GLN A 156 VAL A 163 -1 O ILE A 160 N CYS A 136 SHEET 1 AA2 7 GLN A 30 THR A 35 0 SHEET 2 AA2 7 HIS A 39 HIS A 48 -1 O LEU A 41 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 4 AA2 7 MET A 104 LEU A 108 -1 O LEU A 106 N VAL A 52 SHEET 5 AA2 7 GLU A 81 ILE A 90 -1 N VAL A 89 O LEU A 105 SHEET 6 AA2 7 GLN A 64 LEU A 67 -1 N VAL A 65 O SER A 83 SHEET 7 AA2 7 GLN A 30 THR A 35 -1 N ALA A 32 O PHE A 66 SHEET 1 AA3 8 GLY B 20 PRO B 21 0 SHEET 2 AA3 8 GLN B 156 LEU B 162 -1 O CYS B 157 N GLY B 20 SHEET 3 AA3 8 MET B 180 GLY B 184 -1 O GLY B 184 N HIS B 161 SHEET 4 AA3 8 GLY B 226 ASN B 230 -1 O TYR B 228 N LEU B 181 SHEET 5 AA3 8 HIS B 208 TRP B 215 -1 N TRP B 215 O VAL B 227 SHEET 6 AA3 8 PRO B 198 CYS B 201 -1 N LEU B 199 O GLY B 211 SHEET 7 AA3 8 SER B 135 GLY B 140 -1 N HIS B 137 O VAL B 200 SHEET 8 AA3 8 GLN B 156 LEU B 162 -1 O ILE B 160 N CYS B 136 SHEET 1 AA4 7 GLN B 30 THR B 35 0 SHEET 2 AA4 7 HIS B 39 HIS B 48 -1 O LEU B 41 N LEU B 33 SHEET 3 AA4 7 TRP B 51 THR B 54 -1 O LEU B 53 N VAL B 45 SHEET 4 AA4 7 MET B 104 LEU B 108 -1 O LEU B 106 N VAL B 52 SHEET 5 AA4 7 GLU B 81 ILE B 90 -1 N VAL B 89 O LEU B 105 SHEET 6 AA4 7 GLN B 64 LEU B 67 -1 N LEU B 67 O GLU B 81 SHEET 7 AA4 7 GLN B 30 THR B 35 -1 N TYR B 34 O GLN B 64 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.04 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 3 CYS A 128 CYS A 232 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.01 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.05 SSBOND 7 CYS B 22 CYS B 157 1555 1555 2.03 SSBOND 8 CYS B 42 CYS B 58 1555 1555 2.04 SSBOND 9 CYS B 128 CYS B 232 1555 1555 2.04 SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.04 SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.01 SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.06 CISPEP 1 TYR A 218 PRO A 219 0 -1.16 CISPEP 2 TYR B 218 PRO B 219 0 -4.69 SITE 1 AC1 14 HIS A 57 HIS A 99 ASP A 189 SER A 190 SITE 2 AC1 14 CYS A 191 GLN A 192 SER A 195 VAL A 213 SITE 3 AC1 14 SER A 214 TRP A 215 GLY A 216 ASP A 217 SITE 4 AC1 14 TYR A 218 CYS A 220 SITE 1 AC2 7 PRO A 92 ASP A 93 TYR B 34 PHE B 66 SITE 2 AC2 7 LYS B 70 LEU B 73 HOH B 468 SITE 1 AC3 5 GLN B 101 ASN B 179 ARG B 233 TYR B 234 SITE 2 AC3 5 HOH B 464 SITE 1 AC4 15 GLY A 38 HIS B 57 HIS B 99 ASP B 189 SITE 2 AC4 15 SER B 190 CYS B 191 SER B 195 VAL B 213 SITE 3 AC4 15 SER B 214 TRP B 215 GLY B 216 ASP B 217 SITE 4 AC4 15 CYS B 220 HOH B 482 HOH B 543 CRYST1 58.140 47.400 80.910 90.00 99.08 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017200 0.000000 0.002749 0.00000 SCALE2 0.000000 0.021097 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012516 0.00000